Tenderwize
Wróć do wyszukiwania

Pharmaceutical products

DAPSA·chanteau, France·Deadline Mar 21, 2030 · 1300 days left·Restricted·Supplies
Zarejestruj się, aby zapisać
Oryginalny tytuł ogłoszenia

France-Fleury-les-Aubrais: Pharmaceutical products

35/100

Ocena szansy

Needs reviewMedium complexity
SuppliesOpen
Skąd ta ocena?

Szansa

35 / 100

Złożoność

40 / 100

Czynniki ryzyka

Critical details such as estimated value, eligibility criteria, and required documents are missing. The notice provides...

Structured data indicates a restricted procedure, while XML notice describes a dynamic purchasing system (DPS). This ma...

Restricted procedure — pre-qualification required

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 3 lots
  • Supply of pharmaceutical products (vaccines, medicines, and parapharmacy products) for operational use by the French Ministry of Defence.
  • The contract covers three distinct lots: vaccines, medicines, and parapharmacy products.
Pokaż pełne podsumowanie

This is a restricted procedure notice for the supply of pharmaceutical products (vaccines, medicines, and parapharmacy products) for operational purposes, issued by the French Ministry of Defence (ema/dcssa/daps-ssa). The notice was published on 2022-02-14, but the submission deadline is unusually far in the future (2030-03-21), likely indicating a dynamic purchasing system (DPS) despite structured data flags. Three lots are identified from the XML notice. No estimated value is provided. No procurement documents were analyzed beyond the notice itself.

Ryzyka

Critical details such as estimated value, eligibility criteria, and required documents are missing. The notice provides...

Structured data indicates a restricted procedure, while XML notice describes a dynamic purchasing system (DPS). This ma...

Restricted procedure — pre-qualification required

No procurement documents available

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Procedure is restricted (structured data) but XML indicates a dynamic purchasing system (inconsistency noted).

Administrative

  • Submission is allowed for all lots (based on XML notice: 'TY TYPE BID: Submission for all lots').
  • Language: French (FRA) is required for submission.

Zamawiający

Nazwa

DAPSA

Lokalizacja

chanteau, FRA

Profil zamawiającego

Otwórz profil

Identyfikator

15100002301258

Działalność

Defence

Części (3)

1

vaccins à visée opérationnelle

Supply of vaccines for operational purposes.

Kategoria

Pharmaceutical products

Termin

Deadline Mar 21, 2030

2

médicaments à visée opérationnelle

Supply of medicines for operational purposes.

Kategoria

Pharmaceutical products

Termin

Deadline Mar 21, 2030

3

produits de parapharmacie à visée opérationnelle

Supply of parapharmacy products for operational purposes.

Kategoria

Pharmaceutical products

Termin

Deadline Mar 21, 2030

Szczegóły zamówienia

Data publikacji
14 Feb 2022
Języki
French

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
81444-2022

Podobne przetargi

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30